Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.15 +0.00 (+0.43%)
As of: Oct 22, 2026 · 1:43 PM EDT

Acurx Pharmaceuticals (ACXP) Other Non-Current Assets (2022)

Updated

Acurx Pharmaceuticals (ACXP) reported Other Non-Current Assets of $50,247 for Q2 2022.

Analysis

Acurx Pharmaceuticals (ACXP) Other Non-Current Assets (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 15.10 Bn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn 10.73 Bn
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn -
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn 4.75 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 9.94 Bn
10 Acurx Pharmaceuticals 4.92 Mn -28.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 50,247.00
API Access

Acurx Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACXP&period=max&api_key=YOUR_API_KEY